Market

US Home Prices Surged Almost 20% In October

U.S. home prices surged in October as the housing market remains strong after the COVID-19 pandemic, according to a key economic indicator.

Is the Crack-up Boom Here?

Bloomberg News recently solicited advice from Argentinians who lived through that country’s high inflation on how Americans should cope with rising inflation.

Disney, MLB lead watchdog’s ‘worst of the woke’ list for 2021

Major League Baseball and the Walt Disney Co. top a watchdog’s list of the “worst of the woke” enterprises that displayed intolerance in the name of tolerance this year.

Pfizer Buys Pharmaceutical Company That Makes Heart Medication To Solve The Problem Caused By mRNA Vaccines

Pfizer gearing up to sell a cure for a condition caused by its vaccine

Another 205,000 American Workers File For Unemployment

Another 205,000 American workers filed for unemployment benefits last week, matching the prior week’s jobless claims number and roughly in line with pre-pandemic levels, suggesting that the recent rise in COVID-19 infections was not driving a fresh wave of layoffs.

Major Chinese real estate developer Evergrande totters on the brink; investors fear collapse, which could trigger another major financial liquidity crisis

As if the global economic condition were not severe enough after months of devastating impacts wrought by the COVID-19 pandemic, investors are warning that the possible collapse of a major Chinese real estate development company named Evergrande could trigger a liquidity crisis similar to the one that occurred in late 2008, leading to a multi-year global recession.

Aerospace Industry Leaders Warn Against 5G

Anticipating an expanded 5G plan by Verizon and AT&T, the CEOs of Boeing and Airbus urged the Biden administration to delay it.

The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin

Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.

U.S. Senators Behind Xinjiang Law Have Investments Linked to China’s Uyghur ‘Genocide’

Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.

The Slow Meltdown of the Chinese Economy

Beijing’s troubles are an opportunity for the U.S.—if Washington can recognize it.

Latest news

- Advertisement -spot_img